anonymous
Guest
anonymous
Guest
Let’s be honest: the product never delivered on its original promise. It’s not a long acting toxin. Commercial pressure to drive sales was real. Injectors and patients feel duped. Whoever steps in and takes over will have a hell of a job to turn the situation around.Why so negative? Monday they will announce we are officially one of Crown’s companies. No reason to be so pessimistic. They won’t walk away. It’s too good of a deal.